TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 54 filers reported holding TALARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,587 | +12.6% | 30,458 | +21.8% | 0.00% | – |
| Q2 2023 | $76,030 | -75.2% | 25,010 | -84.7% | 0.00% | – |
| Q1 2023 | $307,120 | +80.7% | 163,362 | -2.0% | 0.00% | – |
| Q4 2022 | $170,004 | -62.8% | 166,670 | -4.1% | 0.00% | – |
| Q3 2022 | $457,000 | -37.7% | 173,738 | +6.8% | 0.00% | – |
| Q2 2022 | $734,000 | -54.6% | 162,683 | -1.0% | 0.00% | – |
| Q1 2022 | $1,618,000 | -37.0% | 164,342 | -2.2% | 0.00% | – |
| Q4 2021 | $2,569,000 | +128.4% | 168,045 | +102.5% | 0.00% | – |
| Q3 2021 | $1,125,000 | -17.5% | 82,987 | -10.6% | 0.00% | – |
| Q2 2021 | $1,363,000 | – | 92,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $5,513,299 | 6.67% |
| BML Capital Management, LLC | 1,929,484 | $3,627,430 | 3.14% |
| Western Standard LLC | 586,481 | $1,102,584 | 1.12% |
| Cormorant Asset Management, LP | 900,649 | $1,693 | 0.11% |
| Artal Group S.A. | 914,262 | $1,719 | 0.10% |
| Values First Advisors, Inc. | 52,896 | $99,445 | 0.06% |
| Blackstone Inc. | 8,089,315 | $15,207,912 | 0.06% |
| Eventide Asset Management | 1,561,092 | $2,934,853 | 0.05% |
| Marquette Asset Management, LLC | 101,375 | $190,585 | 0.05% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $6,184,480 | 0.03% |